<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Anifrolumab</id>
	<title>Anifrolumab - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Anifrolumab"/>
	<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Anifrolumab&amp;action=history"/>
	<updated>2026-04-29T18:49:18Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://idwiki.org/index.php?title=Anifrolumab&amp;diff=11180&amp;oldid=prev</id>
		<title>Aidan: Created page with &quot;* Monoclonal antibody targeting type I interferon (IFN-I) receptor (IFNAR1) * Indicated for systemic lupus erythematosus * Adverse effects include: ** Upper respiratory tract infection ** Nasopharyngitis ** Infusion-related reaction ** Bronchitis ** Urinary tract infection ** Sinusitis ** Increased risk of herpes zoster  Category:Monoclonal antibodies Category:Rheumatology&quot;</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Anifrolumab&amp;diff=11180&amp;oldid=prev"/>
		<updated>2025-07-04T14:26:10Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;* Monoclonal antibody targeting type I interferon (IFN-I) receptor (IFNAR1) * Indicated for &lt;a href=&quot;/Systemic_lupus_erythematosus&quot; title=&quot;Systemic lupus erythematosus&quot;&gt;systemic lupus erythematosus&lt;/a&gt; * Adverse effects include: ** Upper respiratory tract infection ** Nasopharyngitis ** Infusion-related reaction ** Bronchitis ** Urinary tract infection ** Sinusitis ** Increased risk of &lt;a href=&quot;/Varicella-zoster_virus&quot; title=&quot;Varicella-zoster virus&quot;&gt;herpes zoster&lt;/a&gt;  &lt;a href=&quot;/Category:Monoclonal_antibodies&quot; title=&quot;Category:Monoclonal antibodies&quot;&gt;Category:Monoclonal antibodies&lt;/a&gt; &lt;a href=&quot;/index.php?title=Category:Rheumatology&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Category:Rheumatology (page does not exist)&quot;&gt;Category:Rheumatology&lt;/a&gt;&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;* Monoclonal antibody targeting type I interferon (IFN-I) receptor (IFNAR1)&lt;br /&gt;
* Indicated for [[systemic lupus erythematosus]]&lt;br /&gt;
* Adverse effects include:&lt;br /&gt;
** Upper respiratory tract infection&lt;br /&gt;
** Nasopharyngitis&lt;br /&gt;
** Infusion-related reaction&lt;br /&gt;
** Bronchitis&lt;br /&gt;
** Urinary tract infection&lt;br /&gt;
** Sinusitis&lt;br /&gt;
** Increased risk of [[Varicella-zoster virus|herpes zoster]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Monoclonal antibodies]]&lt;br /&gt;
[[Category:Rheumatology]]&lt;/div&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
</feed>